To generate and manage resources towards this goal, the UN Secretary-General in collaboration with UN Agencies, Funds and Programmes (UN AFP) has launched the UN Zika Response Multi-Partner Trust Fund (Zika Response MPTF). The aim of this inter-agency pooled funding mechanism is to rapidly resource ...the UN system responses to Zika virus, in accordance with the overview of needs and requirements and the Zika Response Framework.
more
Reporting period: January 2008-December 2010
Accessed: 29.09.2019
Situation Overview & Humanitarian Needs | July – September 2017
PERC produces regional and member state situation analyses, updated regularly.
The Report describes the evaluation of WHO's contribution to the Maternal Health Program in South-East Asia Region. This was an independent evaluation conducted in 2015 by Amaltas, a Delhi based organization. The evaluation highlights the progress in five countries, namely Bangladesh, Indonesia, Mya...nmar, Nepal and Sri Lanka and provides specific recommendations for Organizational Learning and Development. This report will be useful for all those interested in WHO's work on Maternal Health Program in the Region.
more
Global Conference on Primary Health Care From Alma-Ata towards universal health coverage and the Sustainable Development Goals
Astana, Kazakhstan, 25 and 26 October 2018
As Russia's invasion of Ukraine progresses, the civilian population and the Armed Forces face enormous challenges. It is unsurprising that people's mental health deteriorate in such conditions. This Issue Brief provides publications and informative resources highlighting the impact on Mental Health.
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more